ReWalk $RWLK Gets FDA Clearance to Help Stroke Patients Walk, Stock up 180% - a podcast by Behind The Bid

ReWalk RWLK stock up 180% on getting its ReStore device approved for stroke patients to help them walk.  Stock up 180%

Other stocks covered:

$RWLK: ReWalk 

$MGNX: MacroGenics 

$PVTL: Pivotal Software 

$AMBA: Ambarella 

$QURE: Uniqure 

$GME: Gamestop 

$INRX: InflaRx

Further episodes of Behind The Bid

Further podcasts by Behind The Bid

Website of Behind The Bid